Commentary
Commentary
Insulin prices are falling due to market forces — no price caps required
California State Sen. Scott Wiener, D-San Francisco, recently introduced legislation that would cap cost-sharing for insulin at $35 a month, regardless of whether a patient has public or private insurance. It’s a popular idea. But it may not be necessary. The cost of insulin has been falling due to market ...
Commentary
The CFPB’s New Medical Debt Rule Will Do More Harm Than Good
The Biden administration issued a flurry of directives in its final days. One move in particular warrants closer inspection. On January 7, the Consumer Financial Protection Bureau finalized a rule barring medical debt from appearing on credit reports. According to the agency, the rule will wipe $49 billion in medical ...
Business & Economics
President Trump’s Tariffs Will Harm Your Pocketbook
President Trump fired the first shot of a trade war by imposing 25% tariffs on Canada and 10% tariffs on China, which will take effect on February 4 as of this writing. It also announced 25% tariffs on Mexico, but implementation has been delayed a month while the Administration negotiates ...
Classroom Ideology
Elon Musk needs H-1B workers because math education fails our students
When entrepreneur Elon Musk made headlines with his vociferous comments supporting the H-1B visa program, the ensuing debate focused on the implications of his position on immigration. But this debate obscured the reason America even has such a program in the first place: its homegrown students are being poorly educated ...
Commentary
Give fire victim families emergency school choice
As Gov. Gavin Newsom stood near a burned-down school, Pacific Palisades mom Rachel Darvish pleaded with Newsom: “That was my daughter’s school, what are you going to do?” Newsom offered no real answer for the distraught parent at the time. Well, here’s the answer he should have given: all families ...
Commentary
Patients Pay Dearly for Biden’s Pricing Mess
On Jan. 17, just days before leaving office, the Biden administration announced the next 15 prescription drugs dispensed through Medicare Part D that will be subject to price controls on Jan. 1, 2027, under the terms of the Inflation Reduction Act. Among them is the blockbuster semaglutide, a prescription medication ...
Commentary
RFK Jr.’s Confirmation Hearings Can’t Leave This Question Unanswered
On this Wednesday and Thursday, two powerful Senate committees will hold confirmation hearings for Robert F. Kennedy Jr., President Trump’s nominee to lead the Department of Health and Human Services. RFK Jr. is no stranger to controversy. But his most radical policy position may be one that relatively few people ...
Commentary
Republicans, don’t give up on healthcare reform
In his first week back in the White House, President Donald Trump issued several executive orders related to health policy. But lasting action on healthcare reform, from reining in wasteful or fraudulent Medicaid spending to rolling back billions in premium subsidies, can only come from Congress, which holds the power ...
Commentary
Creative Counting Can’t Fix The Inflation Reduction Act’s Flaws
Just three days before President Biden left office, his appointees tried to tie incoming Trump staffers’ hands on a health policy decision that affects millions of Americans and tens of billions in federal spending. On January 17, the Centers for Medicare & Medicaid Services announced a new list of 15 ...
Commentary
California could lead the way on bipartisan prescription drug reform
California State Senator Scott Wiener, D-San Francisco, recently introduced a bill aimed at reining in pharmacy benefit managers (PBMs), the middlemen largely responsible for the dysfunction plaguing our nation’s prescription drug market. Wiener’s effort should attract the support of lawmakers on both the left and right. By cracking down on ...
Insulin prices are falling due to market forces — no price caps required
California State Sen. Scott Wiener, D-San Francisco, recently introduced legislation that would cap cost-sharing for insulin at $35 a month, regardless of whether a patient has public or private insurance. It’s a popular idea. But it may not be necessary. The cost of insulin has been falling due to market ...
The CFPB’s New Medical Debt Rule Will Do More Harm Than Good
The Biden administration issued a flurry of directives in its final days. One move in particular warrants closer inspection. On January 7, the Consumer Financial Protection Bureau finalized a rule barring medical debt from appearing on credit reports. According to the agency, the rule will wipe $49 billion in medical ...
President Trump’s Tariffs Will Harm Your Pocketbook
President Trump fired the first shot of a trade war by imposing 25% tariffs on Canada and 10% tariffs on China, which will take effect on February 4 as of this writing. It also announced 25% tariffs on Mexico, but implementation has been delayed a month while the Administration negotiates ...
Elon Musk needs H-1B workers because math education fails our students
When entrepreneur Elon Musk made headlines with his vociferous comments supporting the H-1B visa program, the ensuing debate focused on the implications of his position on immigration. But this debate obscured the reason America even has such a program in the first place: its homegrown students are being poorly educated ...
Give fire victim families emergency school choice
As Gov. Gavin Newsom stood near a burned-down school, Pacific Palisades mom Rachel Darvish pleaded with Newsom: “That was my daughter’s school, what are you going to do?” Newsom offered no real answer for the distraught parent at the time. Well, here’s the answer he should have given: all families ...
Patients Pay Dearly for Biden’s Pricing Mess
On Jan. 17, just days before leaving office, the Biden administration announced the next 15 prescription drugs dispensed through Medicare Part D that will be subject to price controls on Jan. 1, 2027, under the terms of the Inflation Reduction Act. Among them is the blockbuster semaglutide, a prescription medication ...
RFK Jr.’s Confirmation Hearings Can’t Leave This Question Unanswered
On this Wednesday and Thursday, two powerful Senate committees will hold confirmation hearings for Robert F. Kennedy Jr., President Trump’s nominee to lead the Department of Health and Human Services. RFK Jr. is no stranger to controversy. But his most radical policy position may be one that relatively few people ...
Republicans, don’t give up on healthcare reform
In his first week back in the White House, President Donald Trump issued several executive orders related to health policy. But lasting action on healthcare reform, from reining in wasteful or fraudulent Medicaid spending to rolling back billions in premium subsidies, can only come from Congress, which holds the power ...
Creative Counting Can’t Fix The Inflation Reduction Act’s Flaws
Just three days before President Biden left office, his appointees tried to tie incoming Trump staffers’ hands on a health policy decision that affects millions of Americans and tens of billions in federal spending. On January 17, the Centers for Medicare & Medicaid Services announced a new list of 15 ...
California could lead the way on bipartisan prescription drug reform
California State Senator Scott Wiener, D-San Francisco, recently introduced a bill aimed at reining in pharmacy benefit managers (PBMs), the middlemen largely responsible for the dysfunction plaguing our nation’s prescription drug market. Wiener’s effort should attract the support of lawmakers on both the left and right. By cracking down on ...
